Literature DB >> 24489097

Human γδ thymocytes are functionally immature and differentiate into cytotoxic type 1 effector T cells upon IL-2/IL-15 signaling.

Julie C Ribot1, Sérgio T Ribeiro, Daniel V Correia, Ana E Sousa, Bruno Silva-Santos.   

Abstract

Cytotoxicity and IFN-γ production by human γδ T cells underlie their potent antitumor functions. However, it remains unclear where and how human γδ T cells acquire these key effector properties. Given the recent disclosure of a major contribution of the thymus to murine γδ T cell functional differentiation, in this study we have analyzed a series of human pediatric thymuses. We found that ex vivo-isolated γδ thymocytes produced negligible IFN-γ and lacked cytolytic activity against leukemia cells. However, these properties were selectively acquired upon stimulation with IL-2 or IL-15, but not IL-4 or IL-7. Unexpectedly, TCR activation was dispensable for these stages of functional differentiation. The effects of IL-2/IL-15 depended on MAPK/ERK signaling and induced de novo expression of the transcription factors T-bet and eomesodermin, as well as the cytolytic enzyme perforin, required for the cytotoxic type 1 program. These findings have implications for the manipulation of γδ T cells in cancer immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24489097     DOI: 10.4049/jimmunol.1303119

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

Review 1.  Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge.

Authors:  Daniel G Pellicci; Hui-Fern Koay; Stuart P Berzins
Journal:  Nat Rev Immunol       Date:  2020-06-24       Impact factor: 53.106

2.  Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism.

Authors:  Georg Gruenbacher; Oliver Nussbaumer; Hubert Gander; Bernhard Steiner; Nicolai Leonhartsberger; Martin Thurnher
Journal:  Oncoimmunology       Date:  2014-11-14       Impact factor: 8.110

3.  Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.

Authors:  Moniek A de Witte; Dhifaf Sarhan; Zachary Davis; Martin Felices; Daniel A Vallera; Peter Hinderlie; Julie Curtsinger; Sarah Cooley; John Wagner; Jurgen Kuball; Jeffrey S Miller
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-02       Impact factor: 5.742

4.  NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer.

Authors:  Joanna Mikulak; Ferdinando Oriolo; Elena Bruni; Alessandra Roberto; Federico S Colombo; Anna Villa; Marita Bosticardo; Ileana Bortolomai; Elena Lo Presti; Serena Meraviglia; Francesco Dieli; Stefania Vetrano; Silvio Danese; Silvia Della Bella; Michele M Carvello; Matteo Sacchi; Giovanni Cugini; Giovanni Colombo; Marco Klinger; Paola Spaggiari; Massimo Roncalli; Immo Prinz; Sarina Ravens; Biagio di Lorenzo; Emanuela Marcenaro; Bruno Silva-Santos; Antonino Spinelli; Domenico Mavilio
Journal:  JCI Insight       Date:  2019-12-19

Review 5.  The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases.

Authors:  David Klatzmann; Abul K Abbas
Journal:  Nat Rev Immunol       Date:  2015-04-17       Impact factor: 53.106

6.  Adoptive cell therapy of patient-derived renal cell carcinoma xenograft model with IL-15-induced γδT cells.

Authors:  Baofu Zhang; Huizhong Li; Wenbin Liu; Hui Tian; Liantao Li; Chao Gao; Junnian Zheng
Journal:  Med Oncol       Date:  2021-02-18       Impact factor: 3.064

7.  Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire.

Authors:  Tanya Dimova; Margreet Brouwer; Françoise Gosselin; Joël Tassignon; Oberdan Leo; Catherine Donner; Arnaud Marchant; David Vermijlen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-23       Impact factor: 11.205

Review 8.  IL-17+ γδ T cells as kick-starters of inflammation.

Authors:  Pedro H Papotto; Julie C Ribot; Bruno Silva-Santos
Journal:  Nat Immunol       Date:  2017-05-18       Impact factor: 25.606

Review 9.  γδ T cells in cancer.

Authors:  Bruno Silva-Santos; Karine Serre; Håkan Norell
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

Review 10.  γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.

Authors:  Bruno Silva-Santos; Sofia Mensurado; Seth B Coffelt
Journal:  Nat Rev Cancer       Date:  2019-07       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.